Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease

Toru Miyoshi, Masayuki Doi, Shinichi Usui, Mutsumi Iwamoto, Masahito Kajiya, Ko Takeda, Kazumasa Nosaka, Rie Nakayama, Keisuke Okawa, Wataru Takagi, Kazufumi Nakamura, Satoshi Hirohata, Hiroshi Itoh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: Secreted frizzled-related protein 5 (SFRP5) is an anti-inflammatory adipokine that is associated with insulin resistance in animals. To extend these observations to humans, we investigated the association of serum SFRP5 levels in subjects with and without coronary artery disease (CAD). Methods: Subjects (n=185, 68±11 years, 79% male) suspected of having CAD were enrolled in the study and were divided into two groups, CAD and non-CAD subjects, according to the results of their coronary angiographies. Serum SFRP5 levels of the subjects were measured by an enzyme-linked immunosorbent assay. Results: The serum SFRP5 levels in the subjects with CAD were significantly lower than those in the non-CAD subjects (median [interquartile range]: 47.7 [26.6] vs. 52.4 [29.6]ng/mL, respectively; p=0.02). The serum SFRP5 levels significantly correlated with body mass index, the homeostasis model of assessment of insulin resistance, adiponectin levels, and CAD severity. Multivariate logistic regression analysis revealed that a decreased serum SFRP5 level (log transformed) was independently associated with CAD for all subjects (adjusted odds ratio, 0.36; 95% confidence interval, 0.14-0.94; p=0.03). Conclusion: Serum SFRP5 levels are significantly associated with CAD in humans, suggesting that low SFRP5 levels may contribute to CAD.

Original languageEnglish
Pages (from-to)454-459
Number of pages6
JournalAtherosclerosis
Volume233
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Adipokines
Coronary Artery Disease
Anti-Inflammatory Agents
Serum
Insulin Resistance
Arteries
FRZB protein
Adiponectin
Coronary Angiography
Body Mass Index
Homeostasis
Logistic Models
Enzyme-Linked Immunosorbent Assay
Odds Ratio
Regression Analysis
Confidence Intervals

Keywords

  • Adipokine
  • Coronary artery disease
  • Inflammation
  • Obesity
  • Secreted frizzled-related protein 5

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. / Miyoshi, Toru; Doi, Masayuki; Usui, Shinichi; Iwamoto, Mutsumi; Kajiya, Masahito; Takeda, Ko; Nosaka, Kazumasa; Nakayama, Rie; Okawa, Keisuke; Takagi, Wataru; Nakamura, Kazufumi; Hirohata, Satoshi; Itoh, Hiroshi.

In: Atherosclerosis, Vol. 233, No. 2, 2014, p. 454-459.

Research output: Contribution to journalArticle

Miyoshi, Toru ; Doi, Masayuki ; Usui, Shinichi ; Iwamoto, Mutsumi ; Kajiya, Masahito ; Takeda, Ko ; Nosaka, Kazumasa ; Nakayama, Rie ; Okawa, Keisuke ; Takagi, Wataru ; Nakamura, Kazufumi ; Hirohata, Satoshi ; Itoh, Hiroshi. / Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. In: Atherosclerosis. 2014 ; Vol. 233, No. 2. pp. 454-459.
@article{f96eec8dd2a14a169e22cb72ef5f3b64,
title = "Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease",
abstract = "Objective: Secreted frizzled-related protein 5 (SFRP5) is an anti-inflammatory adipokine that is associated with insulin resistance in animals. To extend these observations to humans, we investigated the association of serum SFRP5 levels in subjects with and without coronary artery disease (CAD). Methods: Subjects (n=185, 68±11 years, 79{\%} male) suspected of having CAD were enrolled in the study and were divided into two groups, CAD and non-CAD subjects, according to the results of their coronary angiographies. Serum SFRP5 levels of the subjects were measured by an enzyme-linked immunosorbent assay. Results: The serum SFRP5 levels in the subjects with CAD were significantly lower than those in the non-CAD subjects (median [interquartile range]: 47.7 [26.6] vs. 52.4 [29.6]ng/mL, respectively; p=0.02). The serum SFRP5 levels significantly correlated with body mass index, the homeostasis model of assessment of insulin resistance, adiponectin levels, and CAD severity. Multivariate logistic regression analysis revealed that a decreased serum SFRP5 level (log transformed) was independently associated with CAD for all subjects (adjusted odds ratio, 0.36; 95{\%} confidence interval, 0.14-0.94; p=0.03). Conclusion: Serum SFRP5 levels are significantly associated with CAD in humans, suggesting that low SFRP5 levels may contribute to CAD.",
keywords = "Adipokine, Coronary artery disease, Inflammation, Obesity, Secreted frizzled-related protein 5",
author = "Toru Miyoshi and Masayuki Doi and Shinichi Usui and Mutsumi Iwamoto and Masahito Kajiya and Ko Takeda and Kazumasa Nosaka and Rie Nakayama and Keisuke Okawa and Wataru Takagi and Kazufumi Nakamura and Satoshi Hirohata and Hiroshi Itoh",
year = "2014",
doi = "10.1016/j.atherosclerosis.2014.01.019",
language = "English",
volume = "233",
pages = "454--459",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease

AU - Miyoshi, Toru

AU - Doi, Masayuki

AU - Usui, Shinichi

AU - Iwamoto, Mutsumi

AU - Kajiya, Masahito

AU - Takeda, Ko

AU - Nosaka, Kazumasa

AU - Nakayama, Rie

AU - Okawa, Keisuke

AU - Takagi, Wataru

AU - Nakamura, Kazufumi

AU - Hirohata, Satoshi

AU - Itoh, Hiroshi

PY - 2014

Y1 - 2014

N2 - Objective: Secreted frizzled-related protein 5 (SFRP5) is an anti-inflammatory adipokine that is associated with insulin resistance in animals. To extend these observations to humans, we investigated the association of serum SFRP5 levels in subjects with and without coronary artery disease (CAD). Methods: Subjects (n=185, 68±11 years, 79% male) suspected of having CAD were enrolled in the study and were divided into two groups, CAD and non-CAD subjects, according to the results of their coronary angiographies. Serum SFRP5 levels of the subjects were measured by an enzyme-linked immunosorbent assay. Results: The serum SFRP5 levels in the subjects with CAD were significantly lower than those in the non-CAD subjects (median [interquartile range]: 47.7 [26.6] vs. 52.4 [29.6]ng/mL, respectively; p=0.02). The serum SFRP5 levels significantly correlated with body mass index, the homeostasis model of assessment of insulin resistance, adiponectin levels, and CAD severity. Multivariate logistic regression analysis revealed that a decreased serum SFRP5 level (log transformed) was independently associated with CAD for all subjects (adjusted odds ratio, 0.36; 95% confidence interval, 0.14-0.94; p=0.03). Conclusion: Serum SFRP5 levels are significantly associated with CAD in humans, suggesting that low SFRP5 levels may contribute to CAD.

AB - Objective: Secreted frizzled-related protein 5 (SFRP5) is an anti-inflammatory adipokine that is associated with insulin resistance in animals. To extend these observations to humans, we investigated the association of serum SFRP5 levels in subjects with and without coronary artery disease (CAD). Methods: Subjects (n=185, 68±11 years, 79% male) suspected of having CAD were enrolled in the study and were divided into two groups, CAD and non-CAD subjects, according to the results of their coronary angiographies. Serum SFRP5 levels of the subjects were measured by an enzyme-linked immunosorbent assay. Results: The serum SFRP5 levels in the subjects with CAD were significantly lower than those in the non-CAD subjects (median [interquartile range]: 47.7 [26.6] vs. 52.4 [29.6]ng/mL, respectively; p=0.02). The serum SFRP5 levels significantly correlated with body mass index, the homeostasis model of assessment of insulin resistance, adiponectin levels, and CAD severity. Multivariate logistic regression analysis revealed that a decreased serum SFRP5 level (log transformed) was independently associated with CAD for all subjects (adjusted odds ratio, 0.36; 95% confidence interval, 0.14-0.94; p=0.03). Conclusion: Serum SFRP5 levels are significantly associated with CAD in humans, suggesting that low SFRP5 levels may contribute to CAD.

KW - Adipokine

KW - Coronary artery disease

KW - Inflammation

KW - Obesity

KW - Secreted frizzled-related protein 5

UR - http://www.scopus.com/inward/record.url?scp=84896282224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896282224&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2014.01.019

DO - 10.1016/j.atherosclerosis.2014.01.019

M3 - Article

C2 - 24530778

AN - SCOPUS:84896282224

VL - 233

SP - 454

EP - 459

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -